NCT06464172View on ClinicalTrials.gov

Association Between Serum and Neuroimaging Measurements of the GABAergic System

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

July 1, 2026

Conditions
GABAergic System
Interventions
OTHER

Acute Oral gamma-aminobutyric acid (Natural Health Product in Canada)

1800 mg (3 capsules of 600mg) of GABA taken at the research center under the supervision of the research team.

OTHER

Acute Placebo

A capsule filled with powdered sugar taken under the supervision of the research team.

All Listed Sponsors
lead

Francois Corbin

OTHER

NCT06464172 - Association Between Serum and Neuroimaging Measurements of the GABAergic System | Biotech Hunter | Biotech Hunter